IP Verse

Bolloon Catheter For Paclitaxel-Release - EP1857127

The patent EP1857127 was granted to Bayer on Nov 8, 2017. The application was originally filed on Aug 26, 2003 under application number EP07017424A. The patent is currently recorded with a legal status of "Revoked".

EP1857127

BAYER
Application Number
EP07017424A
Filing Date
Aug 26, 2003
Status
Revoked
Jun 25, 2021
Grant Date
Nov 8, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

COOK MEDICALAug 8, 2018WILLIAMS POWELL -
HEMOTEQAug 8, 2018ARTH -
BOSTON SCIENTIFICAug 7, 2018PETERREINS SCHLEY -
BECTONJul 31, 2018HOFFMANN EITLEADMISSIBLE

Patent Citations (42) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5102402
DESCRIPTIONWO0183016
DESCRIPTIONWO9639949
EXAMINATIONWO0021584
EXAMINATIONWO0032238
EXAMINATIONWO0149268
EXAMINATIONWO0152772
EXAMINATIONWO2004006976
EXAMINATIONWO9908729
EXAMINATIONWO9959649
OPPOSITIONDE10115740
OPPOSITIONEP1140273
OPPOSITIONEP1857127
OPPOSITIONUS2001035456
OPPOSITIONUS2001037140
OPPOSITIONUS5102402
OPPOSITIONUS5234547
OPPOSITIONUS5370614
OPPOSITIONUS5916596
OPPOSITIONUS6039721
OPPOSITIONUS6071285
OPPOSITIONWO0021584
OPPOSITIONWO0032238
OPPOSITIONWO0032267
OPPOSITIONWO0033267
OPPOSITIONWO0045744
OPPOSITIONWO0152772
OPPOSITIONWO02065947
OPPOSITIONWO02076509
OPPOSITIONWO0247739
OPPOSITIONWO2004028582
OPPOSITIONWO9418954
OPPOSITIONWO9908729
OTHERWO0021584
OTHERWO0031049
OTHERWO0032238
OTHERWO9908729
SEARCHUS5102402
SEARCHUS5370614
SEARCHWO0183016
SEARCHWO9215282
SEARCHWO9639949

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Alan H. Matsumoto et al, "Peripheral Angioplasty Balloon Technology", Cardiovasc Intervent Radiol., (19930600), vol. 16, no. 3, pages 135 - 143, XP055485041-
OPPOSITION- "Applications of High-Pressure Balloons in the Medical Device Industry", Nordson Medical brochure, (20170000), pages 1 - 17, XP055485785-
OPPOSITION- "C6 Ceramide (d18:1/6:0)", Product Information Sheet, (20180219), XP055507479-
OPPOSITION- Charles R. et al., "Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries", CIRCULATION RESEARCH, (20000000), vol. 87, pages 282 - 288, XP002190356-
OPPOSITION- CURTIS, J. et al., "A comparattive assement of three common catheter materials", Dow Corning Corporation, (20080428), pages 1 - 8, XP055431140-
OPPOSITION- Großmann S., "Neuartige Zubereitungen zur Hemmung der Neointimaproliferation in verengten Arterien", Dissertation Doktors der Naturwissenschaften, Freien Universität Berlin, (20061100), URL: https://refubium.fu-berlin.de/handle/fub188/12873?show=full&locale-attribute=en, XP055518371-
OPPOSITION- "Kapitel 15", LIU, RONG, Water-Insoluble Drug Formation, Interpharm Press, (20000000), pages 525,527,558 - 561, ISBN 1-57491-105-8, XP055518368-
OPPOSITION- Mark A Saab, "Applications of High-Pressure Balloons in the Medical Device Industry", (20000901), URL: https://www.mddionline.com/applications-high-pressure-balloons-medical-device-industry, XP055485778-
OPPOSITION- Mosongo Moukwa, "The Development of Polymer-Based Biomaterials Since the 1920s", JOM, (19970200), vol. 49, no. 2, pages 46 - 50, XP055485050-
OPPOSITION- RAMAKRISHNA S. ET AL, "Biomedical applications of polymer-composite materials: a review", Compositions Science and Technology, (20010000), vol. 61, pages 1189 - 1224, XP055485058-
OPPOSITION- Rapra Review Report 127, (20010700), vol. 11, no. 7, pages 18 - 19, XP055485324-
OPPOSITION- Rong Liu, Water-insoluble drug formation, (20000000), pages 525, 557 - 561, XP055509679-
OPPOSITION- LIGGINS et al., "SOLID-STATE CHARACTERIZATION OF PACLITAXEL", Journal of Pharmaceutical Sciences, (19971200), vol. 86, no. 12, pages 1458 - 1463, XP009027537
OPPOSITION- RICHARDT. LIGGINS et al, "Solid-State Characterization of Paclitaxel", Journal of Pharmaceuticel Sciences, (19971200), vol. 86, no. 12, pages 1458 - 1462, XP009027537
OTHER- "Chapter 15", RONG LIU, Water-Insoluble Drug Formulation, Interpharm Press, (20000000), pages 525,557 - 561, XP055399773-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents